Skip to Content

Tag: Sleep Apnea


Also Noted

Signifier’s CPAP alternative greenlighted by SC Medicaid 

April 8, 2024HME News Staff

BOSTON – Signifier Medical Technologies has announced that its eXciteOSA therapy for sleep-disordered breathing is now covered by South Carolina’s Health Connections Medicaid program. This coverage opens new doors for patients 18 and older who have previously had limited access to advanced treatments for obstructive sleep apnea. "We are thrilled that eXciteOSA is now covered by Medicaid in South Carolina," states Akhil Tripathi, director and co-founder of Signifier. "This...

CPAP Alternative, eXciteOSA, Signifier Medical Technologies, Sleep Apnea


Read Full Articlered right arrow icon

News

ResMed assesses sleep landscape 

March 18, 2024HME News Staff

SAN DIEGO – Fifty-seven percent of respondents say they are aware of sleep apnea, but only 26% of them have been diagnosed with the condition, according to ResMed’s 2024 Global Sleep Survey.  People are becoming more curious about how they sleep, the survey found, with 36% of respondents tracking their sleep either through a smartphone app (44%) or wearable (31%).  “With sleep being the third pillar of health, alongside diet and exercise, prioritizing your sleep...

2024, Global Sleep Survey, ResMed, Sleep Apnea


Read Full Articlered right arrow icon

Also Noted

Samsung expects to launch sleep apnea feature in Q3 

February 12, 2024HME News Staff

RIDGEFIELD PARK, N.J. – Samsung Electronics has announced that the sleep apnea feature on the Samsung Health Monitor app has received de novo authorization from the U.S. Food and Drug Administration. This feature, which detects signs of sleep apnea using a compatible Samsung Galaxy Watch and phone, was the first of its kind to be authorized by the FDA, the company says, following previous approval by Korea’s Ministry of Food and Drug Safety in October. “With the sleep apnea feature,...

App, Samsung, Sleep Apnea


Read Full Articlered right arrow icon

newspoll

News

Industry weighs potential impact of weight loss drugs

November 17, 2023Theresa Flaherty, Managing Editor

YARMOUTH, Maine – Respondents to a recent HME Newspoll aren’t quite sure what to make of the weight loss drug craze and whether or not it will impact demand for certain HME.  Nearly 40% of respondents say the drugs, which are known as GLP-1s and which include brand names like Ozempic and Wegovy, could reduce demand for CPAP devices, as obesity is among the most important risk factors for sleep apnea.  “Over time, I think this will have a huge impact on PAP devices...

Diabetes, Sleep Apnea, weight loss drugs


Read Full Articlered right arrow icon

Providers

Vivos announces deal with Lincare

October 25, 2023HME News Staff

LITTLETON, Colo. – Vivos Therapeutics, a medical technology company that makes oral appliances for patients suffering from mild-to-moderate obstructive sleep apnea and snoring in adults, has signed a distribution agreement with Lincare.  The agreement follows a successful a distribution pilot with Lincare and marks an important milestone in Vivos’ strategy to engage with leading durable medical equipment companies in the United States. Lincare will have a six-month exclusive deal...

Lincare, Oral appliance, Sleep Apnea, Vivos


Read Full Articlered right arrow icon

Also Noted

Vivos appliance gets clinical trial

October 12, 2023HME News Staff

LITTLETON, Colo. – Vivos Therapeutics, a medical technology company focused on developing treatments for patients suffering from mild-to-moderate obstructive sleep apnea and snoring in adults, announced that its flagship daytime-nighttime appliance (DNA) will be tested in a clinical trial at Stanford Medicine. “We are extremely excited to be starting this trial at Stanford Medicine, which has been in the works for some time” said R. Kirk Huntsman, chairman and CEO of Vivos. “I...

Sleep Apnea, Vivos


Read Full Articlered right arrow icon

Also Noted

Apnimed appoints Yee as senior exec

September 20, 2023HME News Staff

CAMBRIDGE, Mass. – Apnimed, a pharmaceutical company focused on developing oral pharmacologic therapies for the treatment of obstructive sleep apnea and related disorders, has appointed John Yee, MD, MPH, as senior vice president of medical affairs. Dr. Yee will lead Apnimed’s efforts to engage and inform the clinical community about the company’s lead drug candidate AD109, as well as other pipeline assets, as they progress through clinical development toward commercial launch....

Apnimed, Sleep Apnea


Read Full Articlered right arrow icon

James Rowley

Specialty Providers

AASM president: Sleep apnea is more than just ‘annoying’ snoring

July 21, 2023Theresa Flaherty, Managing Editor

DARIEN, Ill. – When it comes to awareness of sleep apnea, the message is getting out there, but it’s not amplified enough, says Dr. James Rowley, the American Academy of Sleep Medicine’s new president.  “I think we need to keep reinforcing that message and getting people to think about talking to their primary care doctor,” said Rowley, who is currently transitioning to a new role as a professor of medicine at Rush University Medical Center in Chicago. “Even...

American Academy of Sleep Medicine (AASM), CPAP, Dr. James A. Rowley, Sleep Apnea


Read Full Articlered right arrow icon

Also Noted

Star Sleep & Wellness assembles ‘dream team,’ opens five locations

July 19, 2023HME News Staff

DALLAS and FORT WORTH, Texas – Star Sleep & Wellness has recently opened five locations throughout the Dallas metroplex, in Dallas, Denton, Frisco, Irving and Plano, to offer comprehensive services to patients. Star Sleep & Wellness CEO Dr. Kent Smith has assembled a "dream team" of sleep specialists, including sleep physicians, a licensed psychologist, nurse practitioners, physician assistants and sleep dentists. "Star Sleep & Wellness is able to not only diagnose sleep disorders through testing...

Sleep Apnea, Star Sleep & Wellness


Read Full Articlered right arrow icon

Boone Lockard

Business Development

Sleep therapy market: Keeping calm and carrying on

June 13, 2023Boone Lockard

Editor’s note: It’s been a busy year in the sleep market, as manufacturers rebound from supply chain issues that have plagued them since 2020 and new technologies have launched to increase patient compliance. Boone Lockard, director of VGM Respiratory, recently weighed in on what he’s currently seeing in this dynamic space.  On the challenges and opportunities in the sleep market  Opportunities:  The sleep market presents several significant opportunities...

Boone Lockard, CPAP, Sleep Apnea, VGM Respiratory


Read Full Articlered right arrow icon